Literature DB >> 9916068

The URA5 gene is necessary for histoplasma capsulatum growth during infection of mouse and human cells.

D M Retallack1, E L Heinecke, R Gibbons, G S Deepe, J P Woods.   

Abstract

The Histoplasma capsulatum URA5 gene, which has recently been cloned and disrupted by allelic replacement, encodes orotidine-5'-monophosphate pyrophosphorylase. Inactivation of URA5 by either targeted or UV mutagenesis results in disruption of the pyrimidine biosynthetic pathway and uracil auxotrophy. We examined the effect of uracil auxotrophy due to a ura5 mutation on H. capsulatum virulence in both cell culture and whole-animal models. Uracil auxotrophs of two H. capsulatum restriction fragment length polymorphism classes were found to be avirulent in cultured murine and human cells, as well as in mice. Moreover, virulence could be restored either by supplying a functional URA5 gene in trans or by supplying exogenous uracil during infection in vitro. These experiments demonstrate that the pyrimidine biosynthetic pathway is essential for H. capsulatum growth and virulence.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9916068      PMCID: PMC96364     

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  54 in total

1.  PROMOTION OF RETARDATION OF THE GROWTH OF ADENINE AUXOTROPHS OF CANDIDA ALBICANS BY PURINES, PYRIMIDINES AND NUCLEOSIDES.

Authors:  A SARACHEK
Journal:  Antonie Van Leeuwenhoek       Date:  1964       Impact factor: 2.271

2.  Virulence and Immunizing Capacity of Salmonella Typhimurium as Related to Mutations in Metabolic Requirements.

Authors:  J W Gowen; J Stadler; H H Plough; H N Miller
Journal:  Genetics       Date:  1953-11       Impact factor: 4.562

3.  Pathogenicity of Candida albicans auxotrophic mutants in experimental infections.

Authors:  D R Kirsch; R R Whitney
Journal:  Infect Immun       Date:  1991-09       Impact factor: 3.441

4.  The effects of biochemical mutation on the virulence of Bacterium typhosum; the loss of virulence of certain mutants.

Authors:  G A BACON; T W BURROWS; M YATES
Journal:  Br J Exp Pathol       Date:  1951-04

5.  Digestion of Histoplasma capsulatum yeasts by human macrophages.

Authors:  S L Newman; L Gootee; R Morris; W E Bullock
Journal:  J Immunol       Date:  1992-07-15       Impact factor: 5.422

6.  Molecular and genetic analysis of URA5 transformants of Cryptococcus neoformans.

Authors:  A Varma; J C Edman; K J Kwon-Chung
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

7.  In vivo generation of linear plasmids with addition of telomeric sequences by Histoplasma capsulatum.

Authors:  J P Woods; W E Goldman
Journal:  Mol Microbiol       Date:  1992-12       Impact factor: 3.501

8.  Colony-stimulating factors activate human macrophages to inhibit intracellular growth of Histoplasma capsulatum yeasts.

Authors:  S L Newman; L Gootee
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.441

9.  Inhibition of intracellular growth of Histoplasma capsulatum yeast cells by cytokine-activated human monocytes and macrophages.

Authors:  S L Newman; L Gootee; C Bucher; W E Bullock
Journal:  Infect Immun       Date:  1991-02       Impact factor: 3.441

Review 10.  Histoplasma variation and adaptive strategies for parasitism: new perspectives on histoplasmosis.

Authors:  L G Eissenberg; W E Goldman
Journal:  Clin Microbiol Rev       Date:  1991-10       Impact factor: 26.132

View more
  13 in total

Review 1.  Revisiting old friends: Developments in understanding Histoplasma capsulatum pathogenesis.

Authors:  Jon P Woods
Journal:  J Microbiol       Date:  2016-02-27       Impact factor: 3.422

2.  F901318 represents a novel class of antifungal drug that inhibits dihydroorotate dehydrogenase.

Authors:  Jason D Oliver; Graham E M Sibley; Nicola Beckmann; Katharine S Dobb; Martin J Slater; Laura McEntee; Saskia du Pré; Joanne Livermore; Michael J Bromley; Nathan P Wiederhold; William W Hope; Anthony J Kennedy; Derek Law; Mike Birch
Journal:  Proc Natl Acad Sci U S A       Date:  2016-10-25       Impact factor: 11.205

3.  RNA interference-mediated silencing of the YPS3 gene of Histoplasma capsulatum reveals virulence defects.

Authors:  Megan L Bohse; Jon P Woods
Journal:  Infect Immun       Date:  2007-04-02       Impact factor: 3.441

4.  Expression and interstrain variability of the YPS3 gene of Histoplasma capsulatum.

Authors:  Megan L Bohse; Jon P Woods
Journal:  Eukaryot Cell       Date:  2007-03-02

5.  Histoplasma capsulatum strain variation in both H antigen production and beta-glucosidase activity and overexpression of HAG1 from a telomeric linear plasmid.

Authors:  K L Fisher; G S Deepe; J P Woods
Journal:  Infect Immun       Date:  1999-07       Impact factor: 3.441

6.  Histoplasma capsulatum depends on de novo vitamin biosynthesis for intraphagosomal proliferation.

Authors:  Andrew L Garfoot; Olga Zemska; Chad A Rappleye
Journal:  Infect Immun       Date:  2013-11-04       Impact factor: 3.441

7.  Secreted dipeptidyl peptidase IV activity in the dimorphic fungal pathogen Histoplasma capsulatum.

Authors:  Kendal G Cooper; Jon P Woods
Journal:  Infect Immun       Date:  2009-04-06       Impact factor: 3.441

8.  Sequence elements necessary for transcriptional activation of BAD1 in the yeast phase of Blastomyces dermatitidis.

Authors:  Peggy J Rooney; Bruce S Klein
Journal:  Eukaryot Cell       Date:  2004-06

Review 9.  Histoplasma capsulatum surmounts obstacles to intracellular pathogenesis.

Authors:  Andrew L Garfoot; Chad A Rappleye
Journal:  FEBS J       Date:  2015-11-25       Impact factor: 5.542

Review 10.  Fungal virulence studies come of age.

Authors:  F C Odds; N A Gow; A J Brown
Journal:  Genome Biol       Date:  2001-03-05       Impact factor: 13.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.